Skip to content

Update on rTMS and the First Year Roll-out Experience in the Edmonton Zone

2020 APA Scientific Conference

Please click "Next" if you did not attend this session
200%
The session met the stated learning objectives:
Strongly disagree
Disagree
Somewhat disagree
Neither agree or disagree
Somewhat agree
Agree
Strongly agree
Learn about pharmacotherapy that may hasten relapse in patients receiving rTMS;
Learn about applications of Virtual Reality and Augmented Reality in rTMS training simulations;
Learn about AI, machine learning and EEG biomarkers predicting response to rTMS.
Please rate the following on a scale of 1 to 5
(1 - strongly disagree and 5 - strongly agree):
Strongly disagree
Disagree
Somewhat disagree
Neither agree or disagree
Somewhat agree
Agree
Strongly agree
The session was educationally relevant.
The presenter was educationally effective.
The session provided interactive opportunities.
The session provided opportunities to identify and/or reflect on what was learned and its potential impact on my practice
Please rate the following on a scale of 1 to 5
(1 - strongly disagree and 5 - strongly agree):
Strongly disagree
Disagree
Somewhat disagree
Neither agree or disagree
Somewhat agree
Agree
Strongly agree
The session and presenter did NOT have commercial or other inappropriate bias.
Please provide any other comments you would like to share: